Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson / Synthes: Should the Cash Have Been Used Differently?
Seeking Alpha
Monday, May 2, 2011 - 9:11am
tags:
M&A, JNJ, Synthes
Is Teva's Stock a Bargain by the Numbers?
Motley Fool
Sunday, May 1, 2011 - 4:26pm
tags:
Teva Pharmaceuticals
A Pfizer Clinical Trial and Unanswered Questions
Seeking Alpha
Sunday, May 1, 2011 - 4:24pm
tags:
Pfizer, tofacitinib, rheumatoid arthritis
Zeltia to Miss $10 Million Yondelis Payment After U.S. Setback
Bloomberg
Sunday, May 1, 2011 - 4:23pm
tags:
Zeltia, Yondelis, ovarian cancer, JNJ
A Long Term Buying Opportunity in Spectrum Pharmaceuticals Is Forming
Seeking Alpha
Sunday, May 1, 2011 - 4:21pm
tags:
Spectrum Pharmaceuticals, Fusilev, colorectal cancer
Athersys: Grossly Undervalued Given Its Potential
Seeking Alpha
Sunday, May 1, 2011 - 4:20pm
tags:
Athersys, allogeneic cells, stem cells
The Next Big Thing In Biotech: Dendreon, Avanir (video)
The Street
Sunday, May 1, 2011 - 4:19pm
tags:
Dendreon, Avanir
Glaxo's growth is not an accident: Andrew Witty, global CEO
Economic Times, India
Saturday, April 30, 2011 - 11:36am
tags:
GSK, Andrew Witty
Emerging botulinum toxins enter the cosmetic market
Modern Medicine
Saturday, April 30, 2011 - 11:33am
tags:
botulinum toxin A, Botoxm, Dysport, Xeomin, Merz, PurTox, Mentor, incobotulinumtoxinA
ICON and ACRONET Sign Alliance Agreement For Clinical Development
Bioresearch Online
Saturday, April 30, 2011 - 11:31am
tags:
ICON, ACRONET, clinical development services
Drug Companies Stocks Underperfoming: JNJ, NVS, PFE
Trader's Huddle
Saturday, April 30, 2011 - 11:27am
tags:
JNJ, Novartis, Pfizer
Sellers in Control - Endo Pharmaceuticals
Trader's Huddle
Saturday, April 30, 2011 - 11:26am
tags:
Endo
Merry First-Quarter For Merck As Earnings Triple
Forbes
Saturday, April 30, 2011 - 11:26am
tags:
Merck, earnings
Earnings Preview: Pfizer reports on first quarter
Yahoo/AP
Saturday, April 30, 2011 - 11:24am
tags:
Pfizer, earnings
Nice Efficacy, Pfizer, But...
Motley Fool
Saturday, April 30, 2011 - 10:09am
tags:
Pfizer, tofacitinib, rheumatoid arthritis
Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone
Yahoo/PR NewsWire
Saturday, April 30, 2011 - 10:08am
tags:
Androgel, testosterone, Abbott Laboratories
Genentech, Once Known For Innovation, Is Pursuing A Nexium Strategy With Lucentis
Forbes
Saturday, April 30, 2011 - 10:07am
tags:
Genentech, Lucentis, macular degeneration
Johnson & Johnson’s Centocor Withdraws Trabectedin Application
Bloomberg
Saturday, April 30, 2011 - 10:04am
tags:
JNJ, Janssen Biotech, Trabectedin, ovarian cancer
Fitch considers J&J downgrade on buyout
Yahoo/AP
Saturday, April 30, 2011 - 10:03am
tags:
JNJ
Pfizer!: What Went Wrong This Week and Why? (video)
The Street
Saturday, April 30, 2011 - 10:02am
tags:
Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.